Pub Date : 2009-09-01DOI: 10.1016/S1359-6349(09)70601-9
D. Cella, M. Michaelson, A. Bushmakin, J. Cappelleri, C. Charbonneau, S. Kim, Jim Z. Li, R. Motzer
{"title":"3002 Final quality of life (QOL) results with geographical analysis for sunitinib versus interferon-alfa as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)","authors":"D. Cella, M. Michaelson, A. Bushmakin, J. Cappelleri, C. Charbonneau, S. Kim, Jim Z. Li, R. Motzer","doi":"10.1016/S1359-6349(09)70601-9","DOIUrl":"https://doi.org/10.1016/S1359-6349(09)70601-9","url":null,"abstract":"","PeriodicalId":207270,"journal":{"name":"European Journal of Cancer Supplements","volume":"57 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117276232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}